Cargando…

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes

IMPORTANCE: The incidence of SARS-CoV-2 infection, including among individuals who have received 2 doses of COVID-19 vaccine, increased substantially following the emergence of the Omicron variant in Ontario, Canada. Understanding the estimated effectiveness of 2 or 3 doses of COVID-19 vaccine again...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchan, Sarah A., Chung, Hannah, Brown, Kevin A., Austin, Peter C., Fell, Deshayne B., Gubbay, Jonathan B., Nasreen, Sharifa, Schwartz, Kevin L., Sundaram, Maria E., Tadrous, Mina, Wilson, Kumanan, Wilson, Sarah E., Kwong, Jeffrey C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500552/ https://www.ncbi.nlm.nih.gov/pubmed/36136332 http://dx.doi.org/10.1001/jamanetworkopen.2022.32760

Ejemplares similares

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
por: Grewal, Ramandip, et al.
Publicado: (2023)

Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study
por: Chung, Hannah, et al.
Publicado: (2022)

Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
por: Grewal, Ramandip, et al.
Publicado: (2023)

Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study
por: Jorgensen, Sarah C J, et al.
Publicado: (2023)

Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023)

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
por: Chung, Hannah, et al.
Publicado: (2021)

Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments
por: Sundaram, Maria, et al.
Publicado: (2021)

Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months
por: Jorgensen, Sarah C. J., et al.
Publicado: (2023)

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
por: Nasreen, Sharifa, et al.
Publicado: (2022)

Pregnancy Status at the Time of Coronavirus Disease 2019 Vaccination and Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Magnus, Maria C, et al.
Publicado: (2022)

Effects of sex and birth weight on non-specific health services use following whole-cell pertussis vaccination: a self-controlled case series analysis
por: Hawken, Steven, et al.
Publicado: (2019)

Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination
por: Fell, Deshayne B., et al.
Publicado: (2016)

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2022)

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2023)

Association Between Cycle Threshold Value and Vaccination Status Among Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Cases in Ontario, Canada, in December 2021
por: Ravindran, Saranyah, et al.
Publicado: (2023)

Long covid risk with omicron may be half that of delta
por: Wilson, Clare
Publicado: (2022)

Association between newborn screening analyte profiles and infant mortality
por: Fell, Deshayne B., et al.
Publicado: (2019)

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study
por: Grewal, Ramandip, et al.
Publicado: (2022)

Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancy
por: Török, Eszter, et al.
Publicado: (2023)

Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study
por: Nasreen, Sharifa, et al.
Publicado: (2021)

Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospective cohort study
por: Fell, Deshayne B., et al.
Publicado: (2023)

Peripartum Outcomes Following COVID-19 Vaccination in Late Pregnancy: Findings from a Population-Based Retrospective Cohort Study in Ontario, Canada
por: El-Chaâr, Darine, et al.
Publicado: (2022)

Validation of infant immunization billing codes in administrative data
por: Schwartz, Kevin L, et al.
Publicado: (2015)

Risk of preterm birth, small-for-gestational-age at birth, and stillbirth after receiving a booster dose of COVID-19 vaccine during pregnancy
por: Fell, Deshayne, et al.
Publicado: (2023)

Using newborn screening analytes to identify cases of neonatal sepsis
por: Fell, Deshayne B., et al.
Publicado: (2017)

Risk of preterm birth, small for gestational age at birth, and stillbirth after covid-19 vaccination during pregnancy: population based retrospective cohort study
por: Fell, Deshayne B, et al.
Publicado: (2022)

Pregnancy, fetal, and neonatal outcomes after a first booster dose of covid-19 vaccine during pregnancy in Ontario, Canada: population based, retrospective cohort study
por: Fell, Deshayne B, et al.
Publicado: (2023)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Impact of national recommendations for routine pertussis vaccination during pregnancy on infant pertussis in Ontario, Canada: a population-based time-series study
por: Antoniou, Tony, et al.
Publicado: (2023)

The Detection of Periodic Reemergence Events of SARS-CoV-2 Delta Strain in Communities Dominated by Omicron
por: Westcott, Claire E., et al.
Publicado: (2022)

Delta-Omicron recombinant escapes therapeutic antibody neutralization
por: Duerr, Ralf, et al.
Publicado: (2023)

Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada
por: Peci, Adriana, et al.
Publicado: (2021)

Association between newborn screening analytes and hypoxic ischemic encephalopathy
por: Wilson, Lindsay A., et al.
Publicado: (2019)

Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study
por: Walsh, Laura K, et al.
Publicado: (2019)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

The SARS-CoV-2 Omicron Variant Does Not Have Higher Nasal Viral Loads Compared to the Delta Variant in Symptomatic and Asymptomatic Individuals
por: Laitman, Andrew M., et al.
Publicado: (2022)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Temporal trends in the frequency of twins and higher-order multiple births in Canada and the United States
por: Fell, Deshayne B, et al.
Publicado: (2012)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
por: Bolze, Alexandre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fd0584kvv4usf6lc0kf85afld3